Merck is using AI agents to cut drug discovery cycles by a third and ship compliant marketing materials up to 80% faster — but VP of Digital Platforms Sean Finnerty says the only reason it's working is because they built the infrastructure first.And the pharmaceutical manufacturer is seeing promising early results: AI is generating marketing drafts that are “99% right” when it comes to compliance, shrinking review cycles from months to days and accelerating delivery by 70% to 80%. In the company’s medical research, meanwhile, one AI-assisted discovery cycle was reduced by 33%.Still, agentic AI only works if companies first build the underlying “plumbing,” Finnerty said of digital platforms and services at a recent AI Impact Series event. “If we do one-offs, we're go [...]
In Q1 2026, VentureBeat's Pulse Research surfaced the “Governance Mirage”: the gap between the governance org charts enterprises had drawn and the control layers they had actually built. Fort [...]
Fraud protection is a race against scale. For instance, Mastercard’s network processes roughly 160 billion transactions a year, and experiences surges of 70,000 transactions a second during peak pe [...]
Apple, Mastercard and Visa have successfully dodged a lawsuit that claimed the companies were colluding to maintain the current status quo in point-of-sale-payment card services, Reuters reports. The [...]
Amazon Web Services on Tuesday launched one of the most consequential enterprise AI plays in the company's 20-year history, simultaneously bringing OpenAI's most powerful models to its Bedro [...]
AI agents – task-specific models designed to operate autonomously or semi-autonomously given instructions — are being widely implemented across enterprises (up to 79% of all surveyed for a PwC rep [...]
For the first time on a major AI platform release, security shipped at launch — not bolted on 18 months later. At Nvidia GTC this week, five security vendors announced protection for Nvidia's a [...]